Tyler Woodell is a Nephrology physician affiliated with University of California San Diego. OpenAlex indexes 14 publications with 207 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20253 payments
- Mallinckrodt Hospital Products Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.2%Calcium channel blocker21.3%Amlodipine Besylate75%Nifedipine Er25%Part D<11 patientsAngiotensin receptor blocker (ARB)19%Losartan Potassium75%Valsartan25%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
22.8%SGLT2 inhibitor15.4%Jardiance100%Part D≥19 patientsGLP-1 receptor agonist4.1%Trulicity100%Part D<11 patients+ 1 more class in this area
Genitourinary & hormones
3%alpha-Adrenergic Blocker3%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Paraneoplastic IgAN Associated with Sezary Syndrome
Journal of the American Society of Nephrology
2025 - When Chest Pain Defies Coronary Assumptions, Remember Scleroderma
Journal of the American Society of Nephrology
2025 - ESCAPE! A Nephrology Themed Escape Room Curriculum for Internal Medicine Residents
Journal of the American Society of Nephrology
2024 - Chylous Peritoneal Fluid in a Patient on Peritoneal Dialysis Taking Nifedipine
Journal of the American Society of Nephrology
2021 - Total Carbon Dioxide Versus pH for Determining Acid-Base Status in Patients on Continuous Kidney Replacement Therapy: A Cohort Study
American Journal of Kidney Diseases
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Douglas Richman, MD
University of California San Diego
Robert Weinreb, MD
University of California San Diego
Irene Litvan, MD
University of California San Diego
Dilip Jeste, MD
University of California San Diego
Andrew Levey, MD
Tufts Medical Center
Laura Svetkey, MD
Duke University
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Rajesh V. Thakker
Queen Mary University of London
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”